EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Potential Protective Effects of Resveratrol Against Cabazitaxel-Induced Oxidative Stress and Cardiotoxicity in Rats

Hadeer Khaled iD, Ahmed Farag, Ahmed Elfadadny, Takashi Tanaka, Hany Hassan, Zongru Li, Ahmed Mandour, Ryou Tanaka

Cardiovascular Toxicology · 2026-06 · 26 (6)

DOI: 10.1007/s12012-026-10126-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Toxicology, online erschienen am 27.05.2026. Verfasst von Hadeer Khaled und 7 weiteren Autor:innen. Beteiligte Einrichtung: Veterinary Teaching Hospital, Tokyo University of Agriculture and Technology, Fuchu, Tokyo, 183-8509, Japan. Hauptthemen laut MEDLINE: Resveratrol, Oxidative Stress, Antioxidants, Taxoids. Die Arbeit nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Tokyo University of Agriculture and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cabazitaxel, an anti-prostate cancer agent, is associated with dose-dependent cardiotoxicity mediated by oxidative stress. This study investigated cabazitaxel-induced cardiac injury, the utility of intraventricular pressure gradients for early detection, and the potential protective effects of resveratrol. Twenty male Sprague Dawley rats were allocated into four groups: control, therapeutic cabazitaxel (0.5 mg/kg/week, intraperitoneally), toxic cabazitaxel (1.5 mg/kg/week, intraperitoneally), and toxic cabazitaxel + resveratrol (1.5 mg/kg/week cabazitaxel + 10 mg/kg/day resveratrol, intraperitoneally) for 28 days. Cardiac function was assessed via conventional echocardiography, electrocardiography, and intraventricular pressure gradients under anesthesia. Blood samples and heart tissues were collected for further biochemical and histopathological evaluation. Toxic cabazitaxel administration induced significant RR prolongation and bradycardia compared with controls (RR: 0.21 ± 0.02 vs. 0.18 ± 0.02 s; heart rate: 285.88 ± 31.04 vs. 330.40 ± 27.24 bpm), accompanied by aortic dilatation (aortic diameter: 3.73 ± 0.29 vs. 3.28 ± 0.21 mm), reduced acceleration time to ejection time ratio (0.21 ± 0.04 vs. 0.32 ± 0.12), increased derivatives of reactive oxygen metabolites: 394.75 ± 63.47 vs. 324.80 ± 15.56 U.CARR), elevated platelet counts (121.10 ± 26.48 vs. 81.65 ± 6.49 104/µL), decreased hemoglobin levels (14.26 ± 2.02 vs. 17.66 ± 1.014 g/dL), along with structural myocardial damage. Resveratrol co-administration reduced derivatives of reactive oxygen metabolites (372.40 ± 33.02), normalized aortic diameter, and improved acceleration time to ejection time ratio (3.09 ± 0.40 mm; 0.28 ± 0.06), enhanced electrocardiographic parameters (RR: 0.17 ± 0.01 s; heart rate: 352.24 ± 20.567), restored hemoglobin and platelet counts (15.94 ± 1.39 g/dL; 98.38 ± 28.41 104/µL), and preserved myocardial architecture. However, intraventricular pressure gradient indices remained elevated, and persistent thinning of the left ventricular posterior wall at end-diastole and end-systole was observed. These findings suggest that resveratrol partially mitigates cabazitaxel-induced cardiotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ResveratrolOxidative StressAntioxidantsTaxoidsHeart DiseasesStilbenesAnimalsMaleCardiotoxicityRats, Sprague-DawleyVentricular Function, LeftHeart RateDisease Models, AnimalVentricular PressureMyocardium

Stichwörter der Autor:innen

CabazitaxelCardiotoxicityIntraventricular pressure gradientOxidative stressResveratrol

Substanzen

ResveratrolAntioxidantsTaxoidscabazitaxelStilbenes

Autor:innen und Institutionen

  • Veterinary Teaching Hospital, Tokyo University of Agriculture and Technology, Fuchu, Tokyo, 183-8509, Japan.
  • Department of Medicine and Infectious Diseases (Animal Internal Medicine), Faculty of Veterinary Medicine, University of Sadat City, Sadat City, 32897, Egypt.
  • Department of Surgery, Anesthesiology, and Radiology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt.
  • Department of Animal Internal Medicine, Faculty of Veterinary Medicine, Damanhour University, Damanhour, 22511, Egypt.
  • Department of Animal Medicine (Internal Medicine), Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt.
  • Veterinary Teaching Hospital, Tokyo University of Agriculture and Technology, Fuchu, Tokyo, 183-8509, Japan. fu0253@go.tuat.ac.jp.

ORCID-Profile: Hadeer Khaled

Förderung

  • Tokyo University of Agriculture and Technology

Zitieren

APA

Khaled, H., Farag, A., Elfadadny, A., Tanaka, T., Hassan, H., Li, Z., Mandour, A., & Tanaka, R. (2026). The Potential Protective Effects of Resveratrol Against Cabazitaxel-Induced Oxidative Stress and Cardiotoxicity in Rats. Cardiovascular Toxicology, 26(6). https://doi.org/10.1007/s12012-026-10126-7

Vancouver

Khaled H, Farag A, Elfadadny A, Tanaka T, Hassan H, Li Z, et al. The Potential Protective Effects of Resveratrol Against Cabazitaxel-Induced Oxidative Stress and Cardiotoxicity in Rats. Cardiovascular Toxicology. 2026;26(6). doi:10.1007/s12012-026-10126-7

BibTeX
@article{Khaled2026,
  author = {Khaled, Hadeer and Farag, Ahmed and Elfadadny, Ahmed and Tanaka, Takashi and Hassan, Hany and Li, Zongru and Mandour, Ahmed and Tanaka, Ryou},
  title = {The Potential Protective Effects of Resveratrol Against Cabazitaxel-Induced Oxidative Stress and Cardiotoxicity in Rats},
  journal = {Cardiovascular Toxicology},
  year = {2026},
  volume = {26},
  number = {6},
  doi = {10.1007/s12012-026-10126-7}
}
Kostenlos starten →